New Edge Advisors, LLC Lantern Pharma Inc. Put Options Transaction History
New Edge Advisors, LLC
- $13.5 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LTRN
# of Institutions
40Shares Held
1.27MCall Options Held
42.8KPut Options Held
5.6K-
Vanguard Group Inc Valley Forge, PA364KShares$1.14 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA86.3KShares$270,2660.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny81.8KShares$256,0340.0% of portfolio
-
Cm Management, LLC80KShares$250,4000.35% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA59.8KShares$187,0450.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $33.9M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...